These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17288528)

  • 21. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity.
    Zhang HJ; Yang JJ; Lu JP; Lai CJ; Sheng J; Li YX; Hao Q; Zhang SM; Gupta S
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):672-8. PubMed ID: 19296158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synchronous multifocal osteogenic sarcoma].
    Sulkes A; Biran H
    Harefuah; 1981 Jan; 100(2):74-6. PubMed ID: 6943119
    [No Abstract]   [Full Text] [Related]  

  • 24. Osteosarcoma and other bone cancers.
    Himelstein BP
    Curr Opin Oncol; 1998 Jul; 10(4):326-33. PubMed ID: 9702400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of bone malignancy in adolescence.
    Caudill JS; Arndt CA
    Adolesc Med State Art Rev; 2007 May; 18(1):62-78, ix. PubMed ID: 18605391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteosarcoma.
    Moore DD; Luu HH
    Cancer Treat Res; 2014; 162():65-92. PubMed ID: 25070231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated assessment of potential value of erbB-2 amplification or expression status as novel therapy target in Chinese children and adolescents with osteosarcoma.
    Shang J; Bi ZG; Ji HF; Wang WB
    Chin Med J (Engl); 2009 Jul; 122(13):1521-4. PubMed ID: 19719941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic effects of doctor-associated diagnostic delays in osteosarcoma.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
    Arch Orthop Trauma Surg; 2009 Oct; 129(10):1421-5. PubMed ID: 19280203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel insights and therapeutic interventions for pediatric osteosarcoma.
    Kager L; Tamamyan G; Bielack S
    Future Oncol; 2017 Feb; 13(4):357-368. PubMed ID: 27651036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
    Ek ET; Dass CR; Contreras KG; Choong PF
    Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dissertations 25 years after the date 13. Sarcomas of the jaws].
    Bras J
    Ned Tijdschr Tandheelkd; 2007 Feb; 114(2):87-92. PubMed ID: 17361784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy for osteosarcoma - where does it come from? What is it? Where is it going?
    Yamamoto N; Tsuchiya H
    Expert Opin Pharmacother; 2013 Nov; 14(16):2183-93. PubMed ID: 23919484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. time dependency of prognostic factors in patients with stage II osteosarcomas.
    Kim MS; Cho WH; Song WS; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Oct; 463():157-65. PubMed ID: 17621233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interdisciplinary treatment of osteosarcomas].
    Schultheiss M
    Unfallchirurg; 2014 Jun; 117(6):490. PubMed ID: 24903498
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary malignant bone tumors--a management approach.
    Lange T; Garvin K; Jimenez J; Seibert J; Hutchins L; Hough A; Haynes D
    J Ark Med Soc; 1985 Jul; 82(2):115-9. PubMed ID: 3161865
    [No Abstract]   [Full Text] [Related]  

  • 37. Osteosarcoma and other tumors of bone.
    Mertens WC; Bramwell V
    Curr Opin Oncol; 1995 Jul; 7(4):349-54. PubMed ID: 7578383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption.
    Lamoureux F; Richard P; Wittrant Y; Battaglia S; Pilet P; Trichet V; Blanchard F; Gouin F; Pitard B; Heymann D; Redini F
    Cancer Res; 2007 Aug; 67(15):7308-18. PubMed ID: 17671200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.
    Morrow JJ; Khanna C
    Crit Rev Oncog; 2015; 20(3-4):173-97. PubMed ID: 26349415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bax gene therapy for human osteosarcoma using cationic liposomes in vivo.
    Okumura K; Nakase M; Nakamura S; Kamei T; Inui M; Tagawa T
    Oncol Rep; 2007 Apr; 17(4):769-73. PubMed ID: 17342313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.